Form D · Pharmaceuticals
Paragon Biosciences Emalex Capital, Inc.
Chicaco, IL · CIK 0001749990
Offering snapshot reported Jul 8, 2025 · SEC filing
- Reported sold
- $270M Offering amount: $270M
- Investors reported
- 42 Form D · investor count
- Minimum accepted
- $1.07K Reported outside-investor minimum
- First sale
- May 18, 2022 As reported in this filing
Fundraising history
Reported soldDates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.
What changed?
Latest filing versus its linked predecessor, where available.
- Reported sold$217,000,000 → $270,000,000
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jul 8, 2025 | Amendment | $270,000,000 | $53,000,000vs Mar 25, 2025 | 42 | SEC filing |
| Mar 25, 2025 | Amendment | $217,000,000 | $32,000,000vs Nov 10, 2022 | 42 | SEC filing |
| Nov 10, 2022 | Amendment | $185,000,000 | $0vs Nov 4, 2022 | 42 | SEC filing |
| Nov 4, 2022 | Initial | $185,000,000 | No comparison | 42 | SEC filing |
| Nov 4, 2022 | Initial | $25,000,000 | No comparison | 35 | SEC filing |
| Mar 12, 2021 | Amendment | $35,000,010 | $0vs Mar 12, 2021 | 21 | SEC filing |
| Mar 12, 2021 | Initial | $35,000,010 | No comparison | 21 | SEC filing |
| Oct 3, 2019 | Initial | $37,423,356 | No comparison | 10 | SEC filing |
| Dec 7, 2018 | Amendment | $9,375,000 | $2,450,000vs Aug 14, 2018 | 31 | SEC filing |
| Aug 14, 2018 | Initial | $6,925,000 | No comparison | 15 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- Yes
- Business combination
- No
- Sales commissions
- $5.67M
- Finders' fees
- $0
- Form D file number
- 021-463914
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| Paragon Health Capital, LLC | 300729 |
Source: Form D, filed Jul 8, 2025. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No matching detailed fund disclosure was found in the latest imported ADV filings. This does not establish that the issuer has no adviser.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Jeffrey Aronin | Director |
| Timothy Cunniff | Director |
| Jeffrey Dayno | Director |
| Antonio Gracias | Director |
| Eric Messner | Director, Executive |
| Patrick J. Morris | Executive |
| Darien Parhad | Executive |
| Ricky Sun | Director |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:Chicaco, IL, 60611
Phone: (847) 715-0606